Adimmune Corp (Taiwan) Today
Adimmune Corp is selling for under 22.25 as of the 31st of January 2025; that is 1.83% increase since the beginning of the trading day. The stock's lowest day price was 21.8. The performance scores are derived for the period starting the 3rd of September 2024 and ending today, the 31st of January 2025. Click here to learn more.
Valuation
Check how we calculate scores
Adimmune Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Adimmune Corp's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Adimmune Corp or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Adimmune Corp (4142) is traded on Taiwan Stock Exchange in Taiwan and employs 36 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 17.01 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Adimmune Corp's market, we take the total number of its shares issued and multiply it by Adimmune Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Adimmune Corp operates under Biotechnology sector and is part of Health Care industry. The entity has 421.51 M outstanding shares.
Adimmune Corp has accumulated about 654.9 M in cash with (480.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.76.
Check Adimmune Corp Probability Of Bankruptcy
Adimmune Corp Risk Profiles
Although Adimmune Corp's alpha and beta are two of the key measurements used to evaluate Adimmune Corp's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.65 | |||
| Standard Deviation | 2.61 | |||
| Variance | 6.82 | |||
| Risk Adjusted Performance | (0.05) |
Adimmune Stock Against Markets
Adimmune Corp Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Adimmune Corp stock to make a market-neutral strategy. Peer analysis of Adimmune Corp could also be used in its relative valuation, which is a method of valuing Adimmune Corp by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Adimmune Corp Corporate Management
Elected by the shareholders, the Adimmune Corp's board of directors comprises two types of representatives: Adimmune Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Adimmune. The board's role is to monitor Adimmune Corp's management team and ensure that shareholders' interests are well served. Adimmune Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Adimmune Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Fei Pan | Chief Legal Affairs Officer | Profile | |
| ChinChuan Chang | COO RD | Profile | |
| LiYa Tang | Director Center | Profile | |
| ChihHsiang Leng | Head Division | Profile | |
| ChungCheng Liu | GM Pres | Profile | |
| YinTeng Chang | Chief Officer | Profile | |
| MBA MD | Chief Officer | Profile |
Additional Tools for Adimmune Stock Analysis
When running Adimmune Corp's price analysis, check to measure Adimmune Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adimmune Corp is operating at the current time. Most of Adimmune Corp's value examination focuses on studying past and present price action to predict the probability of Adimmune Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adimmune Corp's price. Additionally, you may evaluate how the addition of Adimmune Corp to your portfolios can decrease your overall portfolio volatility.